ACE Report Cover
Pure Versus Leukocyte Platelet-Rich Plasma Intra-Articular Injections for Knee Cartilage Lesions
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
GENERAL ORTHOPAEDICS
Pure Versus Leukocyte Platelet-Rich Plasma Intra-Articular Injections for Knee Cartilage Lesions .

Clinical Efficacy of Intra-Articular Injection with P-PRP Versus that of L-PRP in Treating Knee Cartilage Lesion: A Randomized Controlled Trial.

Orthop Surg. 2023 Mar; 15(3): 740–749.

Sixty patients with knee cartilage lesions were randomized to receive either an intra-articular injection with pure platelet-rich plasma (P-PRP; n=30) or with leukocyte-rich platelet-rich plasma (L-PRP; n=30). Outcomes of interest included Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain, stiffness, and function as well as pain at rest and with movement measured on a Visual Analog Scale (VAS). WOMAC pain and VAS pain during movement at 6 weeks were significantly better in the P-PRP group. All other outcomes were similar between the two groups at all time points.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. Pure Versus Leukocyte Platelet-Rich Plasma Intra-Articular Injections for Knee Cartilage Lesions. ACE Report. 2023;303(6):7. Available from: https://myorthoevidence.com/AceReport/Show/pure-versus-leukocyte-platelet-rich-plasma-intra-articular-injections-for-knee-cartilage-lesions

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report